Number of death (n = 313) | Total (n = 447) | Crude | Multivariable | |||||
---|---|---|---|---|---|---|---|---|
N (%) | N | Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | |
CHM use (vs. non-CHM use) | ||||||||
 No | 225 (75.50%) | 298 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
 Yes | 88 (59.06%) | 149 | 0.54 | (0.43–0.68) | < 0.0001 | 0.54 | (0.42–0.69) | < 0.0001 |
Age (per year) | ND | ND | 1.02 | (1.01–1.03) | 0.0007 | 1.01 | (1.00–1.02) | 0.0119 |
Gender | ||||||||
 Male | 216 (67.92%) | 318 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
 Female | 97 (75.19%) | 129 | 1.32 | (1.05–1.68) | 0.0196 | 1.03 | (0.80–1.33) | 0.8018 |
Charlson comorbidity index score (per score) | ND | ND | 1.08 | (1.03–1.13) | 0.0023 | 1.07 | (1.01–1.13) | 0.0210 |
Income | ||||||||
  < NT20,000 | 220 (78.85%) | 279 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
 NT20,000-NT30,000 | 58 (53.21%) | 109 | 0.53 | (0.39–0.72) | < 0.0001 | 0.54 | (0.39–0.74) | 0.0001 |
 ≧NT30,000 | 35 (59.32%) | 59 | 0.58 | (0.41–0.82) | 0.0024 | 0.64 | (0.44–0.93) | 0.0203 |